Table 3.

One-year prevalence of indicators of dysfunctional drug use and drug dependence syndrome by gender and gender of sexual partners in previous year

	Dysfunctional use¹								Drug dependence syndrome²
	Men				Women				Men				Women
	Any male partners		Female partners only		Any female partners		Male partners only		Any male partners		Female partners only		Any female partners		Male partners only
Drug class	%	(SE)	%	(SE)	%	(SE)	%	(SE)	%	(SE)	%	(SE)	%	(SE)	%	(SE)
Marijuana	15.0^*	(5.5)	6.6	(0.5)	12.0^*	(4.5)	2.8	(0.3)	5.7^*	(2.5)	2.1	(0.2)	3.9^*	(1.8)	0.9	(0.1)
Cocaine	4.3	(2.2)	2.1	(0.3)	3.2^*	(1.7)	0.9	(0.2)	1.4	(1.4)	0.7	(0.2)	1.1	(0.8)	0.2	(0.1)
Hallucinogens	2.8	(1.6)	1.6	(0.3)	3.4^*	(1.9)	0.8	(0.2)	0.0	(0.0)	0.2	(0.1)	0.4	(0.4)	0.2	(0.1)
Heroin	2.0	(1.4)	0.9	(0.2)	1.5	(1.2)	0.4	(0.1)	0.0	(0.0)	0.2	(0.1)	0.0	(0.0)	0.0	(0.0)
Inhalants	0.6	(0.4)	1.0	(0.3)	0.0	(0.0)	0.4	(0.1)	0.0	(0.0)	0.0	(0.0)	0.0	(0.0)	0.0	(0.0)
Sedatives	0.2	(0.2)	0.8	(0.2)	1.7	(1.3)	0.4	(0.1)	0.0	(0.0)	0.1	(0.1)	0.0	(0.0)	0.1	(0.0)
Stimulants	1.8	(1.2)	1.2	(0.3)	1.1	(1.1)	0.7	(0.1)	0.0	(0.0)	0.3	(0.1)	0.0	(0.0)	0.2	(0.1)
Analgesics	0.2	(0.2)	1.4	(0.3)	0.0	(0.0)	1.0	(0.2)	0.0	(0.0)	0.2	(0.1)	0.0	(0.0)	0.2	(0.1)
Tranquilizers	0.2	(0.2)	1.0	(0.2)	0.0	(0.0)	0.7	(0.2)	0.0	(0.0)	0.2	(0.1)	0.0	(0.0)	0.2	(0.1)
Any drug class	16.0^*	(5.6)	7.7	(0.5)	14.0^*	(4.5)	3.8	(0.4)	5.7	(2.5)	2.8	(2.8)	5.0^*	(2.0)	1.3	(0.2)

Percentages are estimated using sampling weights. Unweighted sample sizes are for homosexually active men (n = 98) and women (n = 96) and heterosexually active men (n = 3922) and women (n = 5792).

Respondent answered yes to any of the six symptoms of drug dependence in the past year.

Respondent answered yes to three or more of six symptoms of drug dependence in the past year.

P < 0.05, when sexual orientation effect evaluated by logistic regression analyses conducted on each gender separately and adjusted for possible demographic confounding.